Radiofrequency Ablation Devices Market Report 2026

Radiofrequency Ablation Devices Market Overview

• Radiofrequency Ablation Devices market size has reached to $5.25 billion in 2025 • Expected to grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: Growing Burden Of Chronic Diseases Fuels Radiofrequency Ablation Devices Market Expansion • Market Trend: Technological Innovation Drives The Radiofrequency Ablation Device Market With Advanced Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Radiofrequency Ablation Devices Market?

Radiofrequency ablation devices are medical devices that generate heat from medium-frequency alternating currents to ablate or destroy abnormal tissue. It destroys cancerous tissue and manages chronic pain by interrupting pain impulses. The main types of radiofrequency ablation devices are disposable equipment, reusable equipment, and capital equipment. Disposable equipment refers to a medical device designed for a single use or short duration. These are used for several applications, including oncology, cardiology and cardiac rhythm management, gynecology, pain management, and others, and are used by various end-users, such as hospitals, ambulatory surgical centers, and others.

What Is The Radiofrequency Ablation Devices Market Growth Forecast?

The radiofrequency ablation devices market size is expected to see rapid growth in the next few years. It will grow to $9.55 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing demand for image-guided oncology treatments, rising adoption of rf ablation in cardiology, expansion of ambulatory surgical procedures, growing focus on targeted pain management, increasing investment in advanced ablation technologies. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of disposable ablation catheters, growing integration of imaging-guided ablation systems, expansion of pain management applications, enhanced focus on precision tissue targeting.

Global Radiofrequency Ablation Devices Market Segmentation

1) By Product Type: Disposable Equipment, Reusable Equipment 2) By Application: Oncology, Cardiology And Cardiac Rhythm Management, Gynecology, Pain Management 3) By End-User: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Disposable Equipment: Ablation Catheters, Electrode Pads, Temperature Probes 2) By Reusable Equipment: RF Generators, Handpieces

What Is The Driver Of The Radiofrequency Ablation Devices Market?

Increasing chronic diseases are driving the growth of the radiofrequency ablation devices market going forward. Chronic diseases are problems that last a year or longer, necessitating continuing medical care, restricting everyday activities, or both. Radiofrequency ablation devices are used in chronic diseases to relieve people with chronic and arthritic joint pain. It is often used to shrink the size of tumors, nodules, or other growths in the body. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. As a result, increasing chronic diseases are propelling the growth of the radiofrequency ablation devices industry.

Key Players In The Global Radiofrequency Ablation Devices Market

Major companies operating in the radiofrequency ablation devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, AngioDynamics Inc, AtriCure Inc, Stryker Corporation, Smith and Nephew plc, CONMED Corporation, Hologic Inc, Olympus Corporation, BIOTRONIK SE and Co KG, Baylis Medical Company Inc, Avanos Medical Inc, Cosman Medical Inc, Lepu Medical Technology Co Ltd, RF Medical Co Ltd, Gynesonics Inc, Cutera Inc, MicroPort Scientific Corporation, Merit Medical Systems Inc, ENDO-FLEX GmbH, Bramsys Industria e Comercio Ltd

Global Radiofrequency Ablation Devices Market Trends and Insights

Major companies operating in the radiofrequency ablation devices market are increasing their focus on introducing advanced medical devices, such as the ELIOSTAR Balloon Ablation Catheter, to gain a competitive edge in the market. The ELIOSTAR Balloon Ablation Catheter is an advanced medical device designed for cardiac ablation procedures, utilizing innovative technology to treat arrhythmias and enhance precision in electrophysiological interventions. For instance, in April 2023, Compal Electronics, a Taiwan-based electronics company, launched AblatePal, a new radiofrequency ablation (RFA) system for percutaneous and intraoperative coagulation and ablation of soft tissue. This RFA system uses the heat energy produced by electrical resistance when current flows through the tissue to cauterize the tumor and cause tumor necrosis. Its advanced cooling technology prevents damage to normal tissue and has positive results that can reduce the size of the wound and shorten the length of time patients must stay in the hospital.

What Are Latest Mergers And Acquisitions In The Radiofrequency Ablation Devices Market?

In June 2023, Avanos Medical, Inc., a U.S.-based medical technology company, acquired Diros Technology Inc. for $53 million. Through this acquisition, Avanos plans to enhance its chronic pain treatment offerings by integrating Diros’s Trident RF tined probe technology alongside its existing COOLIEF cooled RF products, thereby expanding its minimally invasive, non opioid pain management portfolio. Diros Technology is a Canada-based developer of radiofrequency (RF) ablation devices.

Regional Outlook

North America was the largest region in the radiofrequency ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Radiofrequency Ablation Devices Market?

The radiofrequency ablation devices market consists of sales of catheters, thermopads, and hard tissue introducers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.